Status:
COMPLETED
Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers (REPICOV-AKI)
Lead Sponsor:
Jesus Rivero, MD
Conditions:
COVID-19
Anxiety
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The frequency of psychological conditions in recovered COVID-19 patients with Acute Kidney Injury (AKI) and their informal primary caregivers (IPC) is unknown; as well as the effects of psychological ...
Eligibility Criteria
Inclusion
- Survivors of severe COVID-19 who had AKI during hospitalization
- Informal primary caregivers
Exclusion
- They did not accept to participate in the study
- They did not answer three attempted phone calls or text messages making it impossible to complete the intervention.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT06522776
Start Date
March 1 2021
End Date
July 1 2024
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Respiratory Diseases
Mexico City, Mexico City, Mexico, 14080